The company said, “Fourth quarter 2025 reported preliminary unaudited revenue in the range of approximately $389 million to $395 million, up approximately 10% to 11% year-over-year.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical chair Fred Lampropoulos resigns, F. Ann Millner succeeds
- Merit Medical price target raised to $99 from $93 at Canaccord
- Merit Medical price target raised to $108 from $103 at Baird
- Hold Rating for Merit Medical Systems Due to Pending Long-term Data and Pricing Challenges for WRAPSODY Stent
- Merit Medical price target lowered to $93 from $104 at Canaccord